サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1781607

臨床栄養の世界市場：産業分析、市場規模・シェア・成長率・動向・予測 (2025～2033年)

Global Clinical Nutrition Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 144 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.67円
臨床栄養の世界市場：産業分析、市場規模・シェア・成長率・動向・予測 (2025～2033年)
出版日: 2025年08月01日
発行: Value Market Research
ページ情報: 英文 144 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床栄養の市場規模は、2024年の373億5,000万米ドルから2033年には628億8,000万米ドルに成長し、2026～2033年の予測期間中に5.96％の堅調な年間平均成長率（CAGR）を示すと予測されます。

臨床栄養市場は、慢性疾患の有病率の増加やヘルスケアにおける栄養の重要性に対する意識の高まりに牽引され、大幅な成長が見込まれています。医療提供者が疾病予防と管理における栄養の重要な役割を認識するにつれて、特殊な栄養補助食品、経腸栄養製剤、医療用食品を含む臨床栄養製品に対する需要が急増しています。この動向は、個別化医療に向けた広範なシフトを反映しており、そこでは患者の特定のニーズに合わせて栄養を調整することで、治療結果や全体的な健康状態を向上させています。

さらに、研究と技術の進歩が臨床栄養学の展望を形成しています。現在進行中の研究により、栄養と様々な健康状態との関連性が明らかになりつつあり、特定の患者のニーズに対応する的を絞った栄養介入の開発につながっています。遠隔医療やモバイルヘルスアプリなどのデジタルヘルス技術の統合も臨床栄養サービスの提供を促進しており、ヘルスケアプロバイダーは患者の進行状況をモニターし、食事に関する推奨事項をリアルタイムで調整できるようになっています。市場が進化を続けるにつれて、焦点は患者とヘルスケア提供者の多様なニーズに応える革新的な臨床栄養ソリューションの創造に移っていくと思われます。

さらに、予防ヘルスケアを重視する傾向が強まっていることも、臨床栄養市場に影響を与えています。消費者が健康に対してより積極的になるにつれて、全体的な健康維持と疾病予防をサポートする栄養製品に対する需要が増加しています。健康とウェルネスに対する消費者の関心の高まりに合わせて、メーカー各社がエビデンスに基づく臨床栄養製品の開発を模索しているため、こうした予防重視の姿勢が研究開発への投資を促進しています。臨床栄養市場の将来は、継続的な技術革新、品質へのこだわり、患者ケアと健康アウトカムを向上させる効果的な栄養ソリューションの提供に重点を置くことが特徴になるでしょう。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細情報。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品、用途、地域などの基準に基づき、市場を明確なセグメントに内訳しています。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価を行っています。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 臨床栄養：産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接的マーケティング
    • 間接的マーケティング
    • マーケティングチャネル発展動向

第5章 臨床栄養市場の分析：製品別

  • 市場概要：製品別
  • 実績・予測データ分析：製品別
  • 経口臨床栄養
  • 非経口栄養剤
  • 経腸栄養剤

第6章 臨床栄養市場の分析：用途別

  • 市場概要： 用途別
  • 実績・予測データ分析：用途別
  • アルツハイマー病
  • 栄養不足
  • がんケア
  • 糖尿病
  • 慢性腎臓病
  • 希少疾患
  • 嚥下障害
  • 疼痛管理
  • 吸収不良/胃腸障害/下痢
  • その他

第7章 臨床栄養市場の分析：販売チャネル別

  • 市場概要：販売チャネル別
  • 実績・予測データ分析：販売チャネル別
  • 小売販売チャネル
  • オンライン販売チャネル
  • 施設販売チャネル

第8章 臨床栄養市場の分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上高の分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上高の分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域の売上高の分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカの売上高の分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上高の分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 臨床栄養企業の競合情勢

  • 臨床栄養市場の競合
  • 提携/協力/合意
  • 合併と買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Abbott Nutrition
  • Pfizer Inc.
  • Bayer AG
  • Nestle
  • Baxter International Inc.
  • Otsuka Holdings Co. Ltd.
  • Mead Johnson & Company LLC
  • Danone（Nutricia）
  • Victus Inc.
  • Fresenius Kabi
  • Meiji Holdings. Co. Ltd.
  • Abbvie（Allergan）
  • Baxter
  • Grifols
  • S.A
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Oral Clinical Nutrition Market Sales By Geography (USD MN)
  • Parenteral Nutrition Market Sales By Geography (USD MN)
  • Enteral Feeding Formulas Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Alzheimer's Disease Market Sales By Geography (USD MN)
  • Nutrition Deficiency Market Sales By Geography (USD MN)
  • Cancer Care Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Chronic Kidney Diseases Market Sales By Geography (USD MN)
  • Orphan Diseases Market Sales By Geography (USD MN)
  • Dysphagia Market Sales By Geography (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Malabsorption/GI Disorder/Diarrhea Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Sales Channel (USD MN)
  • Retail Sales Channels Market Sales By Geography (USD MN)
  • Online Sales Channels Market Sales By Geography (USD MN)
  • Institutional Sales Channels Market Sales By Geography (USD MN)
  • Global Clinical Nutrition Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Clinical Nutrition Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Nutrition Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Sales Channel
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Oral Clinical Nutrition Market Sales By Geography (USD MN)
  • Parenteral Nutrition Market Sales By Geography (USD MN)
  • Enteral Feeding Formulas Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Alzheimer's Disease Market Sales By Geography (USD MN)
  • Nutrition Deficiency Market Sales By Geography (USD MN)
  • Cancer Care Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Chronic Kidney Diseases Market Sales By Geography (USD MN)
  • Orphan Diseases Market Sales By Geography (USD MN)
  • Dysphagia Market Sales By Geography (USD MN)
  • Pain Management Market Sales By Geography (USD MN)
  • Malabsorption/GI Disorder/Diarrhea Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Sales Channel (USD MN)
  • Retail Sales Channels Market Sales By Geography (USD MN)
  • Online Sales Channels Market Sales By Geography (USD MN)
  • Institutional Sales Channels Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113875

Global Clinical Nutrition Market size is anticipated to grow from USD 37.35 Billion in 2024 to USD 62.88 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.96% during the forecast period of 2026 to 2033.

The clinical nutrition market is poised for significant growth, driven by the increasing prevalence of chronic diseases and the rising awareness of the importance of nutrition in healthcare. As healthcare providers recognize the critical role of nutrition in disease prevention and management, the demand for clinical nutrition products, including specialized dietary supplements, enteral nutrition formulas, and medical foods, is surging. This trend reflects a broader shift towards personalized medicine, where nutrition is tailored to meet the specific needs of patients, enhancing treatment outcomes and overall health.

Moreover, advancements in research and technology are shaping the clinical nutrition landscape. Ongoing studies are uncovering the links between nutrition and various health conditions, leading to the development of targeted nutritional interventions that address specific patient needs. The integration of digital health technologies, such as telehealth and mobile health applications, is also facilitating the delivery of clinical nutrition services, allowing healthcare providers to monitor patient progress and adjust dietary recommendations in real-time. As the market continues to evolve, the focus will shift towards creating innovative clinical nutrition solutions that cater to the diverse needs of patients and healthcare providers.

Additionally, the increasing emphasis on preventive healthcare is influencing the clinical nutrition market. As consumers become more proactive about their health, the demand for nutritional products that support overall well-being and disease prevention is on the rise. This focus on prevention is driving investment in research and development, as manufacturers seek to create evidence-based clinical nutrition products that align with the growing consumer interest in health and wellness. The future of the clinical nutrition market will be characterized by continuous innovation, a commitment to quality, and a focus on delivering effective nutritional solutions that enhance patient care and health outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

  • Oral Clinical Nutrition
  • Parenteral Nutrition
  • Enteral Feeding Formulas

By Application

  • Alzheimer's Disease
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

By Sales Channel

  • Retail Sales Channels
  • Online Sales Channels
  • Institutional Sales Channels
  • COMPANIES PROFILED
  • Abbott Nutrition
  • Pfizer Inc.
  • Bayer AG
  • Nestle
  • Baxter International Inc.
  • Otsuka Holdings Co. Ltd.
  • Mead Johnson & Company LLC
  • Danone (Nutricia)
  • Victus Inc.
  • Fresenius Kabi
  • Meiji Holdings. Co. Ltd.
  • Abbvie (Allergan)
  • Baxter
  • Grifols
  • S.A.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CLINICAL NUTRITION INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Sales Channel
    • 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CLINICAL NUTRITION MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Oral Clinical Nutrition Historic and Forecast Sales By Regions
  • 5.4. Parenteral Nutrition Historic and Forecast Sales By Regions
  • 5.5. Enteral Feeding Formulas Historic and Forecast Sales By Regions

6. GLOBAL CLINICAL NUTRITION MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Alzheimer's Disease Historic and Forecast Sales By Regions
  • 6.4. Nutrition Deficiency Historic and Forecast Sales By Regions
  • 6.5. Cancer Care Historic and Forecast Sales By Regions
  • 6.6. Diabetes Historic and Forecast Sales By Regions
  • 6.7. Chronic Kidney Diseases Historic and Forecast Sales By Regions
  • 6.8. Orphan Diseases Historic and Forecast Sales By Regions
  • 6.9. Dysphagia Historic and Forecast Sales By Regions
  • 6.10. Pain Management Historic and Forecast Sales By Regions
  • 6.11. Malabsorption/GI Disorder/Diarrhea Historic and Forecast Sales By Regions
  • 6.12. Others Historic and Forecast Sales By Regions

7. GLOBAL CLINICAL NUTRITION MARKET ANALYSIS BY SALES CHANNEL

  • 7.1. Overview By Sales Channel
  • 7.2. Historical and Forecast Data Analysis By Sales Channel
  • 7.3. Retail Sales Channels Historic and Forecast Sales By Regions
  • 7.4. Online Sales Channels Historic and Forecast Sales By Regions
  • 7.5. Institutional Sales Channels Historic and Forecast Sales By Regions

8. GLOBAL CLINICAL NUTRITION MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CLINICAL NUTRITION COMPANIES

  • 9.1. Clinical Nutrition Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF CLINICAL NUTRITION INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott Nutrition
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Pfizer Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Bayer AG
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Nestle
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Baxter International Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Otsuka Holdings Co. Ltd.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Mead Johnson & Company LLC
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Danone (Nutricia)
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Victus Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Fresenius Kabi
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Meiji Holdings. Co. Ltd.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Abbvie (Allergan)
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Baxter
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Grifols
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. S.A
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies